tiprankstipranks
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market
CONCORDBIO
Concord Biotech Ltd.
RESEARCH TOOLSreports
Want to see IN:CONCORDBIO full AI Analyst Report?

Concord Biotech Ltd. (CONCORDBIO) Financial Statements

2 Followers

Concord Biotech Ltd. Financial Overview

Concord Biotech Ltd.'s market cap is currently ₹116.70B. The company's EPS TTM is ₹30.92; its P/E ratio is 54.58; and it has a dividend yield of 0.80%. Concord Biotech Ltd. is scheduled to report earnings on May 21, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 12.00B₹ 10.17B₹ 8.53B₹ 7.13B₹ 6.17B
Gross Profit₹ 7.68B₹ 6.67B₹ 6.61B₹ 5.41B₹ 5.00B
Operating Income₹ 6.02B₹ 5.21B₹ 5.18B₹ 4.16B₹ 4.30B
EBITDA₹ 5.13B₹ 4.39B₹ 3.53B₹ 2.78B₹ 3.29B
Net Income₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B₹ 2.35B
Balance Sheet
Cash & Short-Term Investments₹ 3.18B₹ 2.86B₹ 1.81B₹ 1.62B₹ 2.01B
Total Assets₹ 20.34B₹ 17.01B₹ 15.14B₹ 13.13B₹ 11.83B
Total Debt₹ 29.69M₹ 97.38M₹ 315.47M₹ 624.93M₹ 892.83M
Net Debt₹ 17.86M₹ -54.05M₹ 280.48M₹ 618.26M₹ 841.39M
Total Liabilities₹ 2.22B₹ 1.74B₹ 2.24B₹ 2.10B₹ 1.83B
Stockholders' Equity₹ 18.13B₹ 15.27B₹ 12.90B₹ 11.03B₹ 9.99B
Cash Flow
Free Cash Flow₹ 1.36B₹ 1.80B₹ 1.01B₹ 519.70M₹ -373.59M
Operating Cash Flow₹ 2.47B₹ 2.65B₹ 2.46B₹ 2.07B₹ 1.67B
Investing Cash Flow₹ -1.63B₹ -1.55B₹ -1.58B₹ -1.12B₹ -1.95B
Financing Cash Flow₹ -986.67M₹ -992.15M₹ -852.19M₹ -1.00B₹ 311.24M
Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

Income Statement >

Concord Biotech Ltd. Debt to Assets

Balance Sheet >

Concord Biotech Ltd. Cash Flow

Cash Flow >

Concord Biotech Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >